Atopic Dermatitis: Research and Clinical Updates and Perspectives
This Special Issue on Atopic Dermatitis focuses on novel insights into the pathogenesis of the immunological components of the disorder and the impaired epidermal barrier properties. It also explores the efficacy and safety of breakthrough therapies with topical agents and systemic therapies, such a...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_128681 | ||
005 | 20231130 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20231130s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-9205-3 | ||
020 | |a 9783036592046 | ||
020 | |a 9783036592053 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-9205-3 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Gregoriou, Stamatis |4 edt | |
700 | 1 | |a Gregoriou, Stamatis |4 oth | |
245 | 1 | 0 | |a Atopic Dermatitis: Research and Clinical Updates and Perspectives |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (172 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a This Special Issue on Atopic Dermatitis focuses on novel insights into the pathogenesis of the immunological components of the disorder and the impaired epidermal barrier properties. It also explores the efficacy and safety of breakthrough therapies with topical agents and systemic therapies, such as monoclonals and JAK inhibitors. The aim of this Special Issue is also to present the expected future forefront of research and the treatment options that are expected to be available in the next few years. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a atopic dermatitis | ||
653 | |a dupilumab | ||
653 | |a skin barrier | ||
653 | |a transepidermal water loss | ||
653 | |a n/a | ||
653 | |a dexpanthenol | ||
653 | |a topical corticosteroid | ||
653 | |a emollient | ||
653 | |a psoriasis | ||
653 | |a mesenchymal stem cells | ||
653 | |a biologics | ||
653 | |a therapy | ||
653 | |a regenerative medicine | ||
653 | |a topical treatment | ||
653 | |a JAK inhibitors | ||
653 | |a PDE-4 inhibitors | ||
653 | |a information campaign | ||
653 | |a early diagnosis | ||
653 | |a comorbidities | ||
653 | |a patterns | ||
653 | |a network analysis | ||
653 | |a cancer | ||
653 | |a real-world study | ||
653 | |a biological therapy | ||
653 | |a human epidermis | ||
653 | |a immunofluorescence | ||
653 | |a transmission electron microscopy | ||
653 | |a keratinocytes | ||
653 | |a interleukins | ||
653 | |a toll-like receptors | ||
653 | |a human beta-defensin 2 | ||
653 | |a involucrin | ||
653 | |a filaggrin | ||
653 | |a claudin-1 | ||
653 | |a exposome | ||
653 | |a age | ||
653 | |a skin of color | ||
653 | |a COVID-19 | ||
653 | |a war | ||
653 | |a intrinsic atopic dermatitis | ||
653 | |a atopic | ||
653 | |a child | ||
653 | |a dermatitis | ||
653 | |a family | ||
653 | |a quality of life | ||
653 | |a narrow-band UVB phototherapy | ||
653 | |a ultraviolet A1 phototherapy | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/8143 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/128681 |7 0 |z DOAB: description of the publication |